Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 4 of the 6 sources its claims cite were checked for support.
Abstract
An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo. Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses. Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons, this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.
Overview
CoChat Summary
## TL;DR
In aged telomerase-deficient TERT-ER mice, a 4-week course of 4-OHT-induced telomerase reactivation reversed multiple degenerative phenotypes rather than merely halting them. The treatment restored telomere signal and reduced DNA damage responses, with functional recovery in testes, spleen, intestine, brain myelination, and innate olfactory behavior.
## Key findings
- G4 TERT-ER mice phenocopied late-generation telomerase-deficient mice and had reduced survival: median survival was 43.5 vs. 86.8 weeks for telomere-intact mice.
- After 4 weeks of 4-OHT, telomerase reactivation increased telomere-FISH signal, reduced p53 activation, reduced p21 expression, and decreased 53BP1 foci in splenocytes and intestinal crypt cells.
- Telomerase reactivation reversed tissue degeneration, including restoration of normal testes and spleen size, reduced apoptosis in testes germ cells and intestinal crypt cells, and increased fecundity.
- In the brain, treatment restored Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocytes; brain weight improved from 77.3 ± 3.3% to 89.7 ± 4.0% of G0 levels, and the myelin g-ratio shifted from 0.7756 ± 0.0054 in G4 mice toward 0.7058 ± 0.0006 after treatment.
- Innate olfactory avoidance recovered: untreated G4 mice failed to avoid lower 2-MB concentrations, but after 4-OHT they showed avoidance at all tested concentrations (1.87 × 10^-4 M to 1.87 × 10^-6 M).
## Methods
- The authors generated a knock-in TERT-ER mouse with a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-estrogen receptor fusion under the endogenous TERT promoter; studies used adult male mice, typically 30–35 weeks old, across successive generations (G0 to G4).
- They assessed telomerase activity, telomere status, DNA damage markers, histology, neurosphere self-renewal and differentiation, myelination, and olfactory behavior using TRAP assays, IHC/FISH, cell culture, electron microscopy, and behavioral testing.
- Statistical analysis used one-way ANOVA with Bonferroni post test and Mantel-Cox tests for survival curves.
## Limitations
- The paper states that carcinogenesis was not observed after the brief telomerase reactivation course, but also notes this was “data not shown” and that longer or later-life reactivation may provoke carcinogenesis.
- The study was performed on adult males only, so the text makes evident a sex limitation.
- The olfactory test sample sizes were small in the methods (n=4 per experimental condition), which is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 Valid · 0 Not valid · 1 Not checked · 19 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, G4 TERT-ER mice phenocopy late generation mTert -/- and mTerc -/- animals 13 , 14 , indicating that TERT-ER is inactive in the absence of 4-OHT.”
What the sources say
- Partly supportedcites [13] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997) sourceExperimental — accuracy not yet measured
The Abstract reports progressive telomere loss and frequent chromosomal rearrangements in later generations of mTR−/− mice, supporting the comparison to mTerc−/− animals. It does not study mTert−/− or TERT-ER mice, so it cannot establish that G4 TERT-ER mice phenocopy both groups. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [14] Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003) source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with the integral role of SVZ neural progenitors in generation and maintenance of olfactory bulb interneurons 2 , this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Figure 2. Telomerase activation in adult TERT-ER mice”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
13 more claims
Create a free account to see all 23 claims and every source verdict.
- It may state two separate claims as one. 2
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice, segmental premature ageing only manifest in telomerase mutants after several generations, likely because their particularly long telomeric repeats take several generations to become critically shortened and thus dysfunctional16.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“neural stem cells from mTERC-reactivated animals showed enhanced multipotency, suggesting recovered neurogenic function.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice with telomerase deficiency serve as a robust model for studying anti-aging effects as they closely resemble natural aging and reflect various pathophysiological states during the aging process, making them more representative compared to other aging mouse models induced by different methods (Jaskelioff et al., 2011).”
From Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model (2023) · cites this paper as Jaskelioff et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in post-mitotic neurons, restoration of physiological TERT levels improve capacity for neural stem cell regeneration, enhance synaptic plasticity and preserve cognitive function in two models of Alzheimer’s Disease.15,16”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in genetically engineered mice, TERT reactivation studies revealed the dual role of TERT in the reversal of aging via telomere synthesis in proliferative tissues as well as via gene expression modulation in post-mitotic tissues in a telomere-independent manner.”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Innate olfactory avoidance test
“For innate avoidance tests, circular filter paper (2.5cm diameter) was scented with 40 μl of either water or progressively higher concentrations of 2-MB (1.74 × 10 -6 M through 1.74 × 10 -4 M)”
§ Abstract
“Whereas G0 TERT-ER mice demonstrated avoidance responses at all 2-MB concentrations tested (1.87×10 -4 M through 1.87×10 -6 M), G4 mice showed attraction/neutral behaviors at concentrations lower than 1.87×10 -4 M (Figure 5e,f).”
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,104
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationLinking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759
Self-citationHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
Self-citationInnate versus learned odour processing in the mouse olfactory bulb
Kobayakawa, K., Kobayakawa, R., Matsumoto, H., Oka, Y., Imai, T., Ikawa, M., Okabe, M., Ikeda, T., Itohara, S., Kikusui, T., et al. (2007) · Nature · doi:10.1038/nature06281 · Cited by 671
Chan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
Cited by
Items 801–848 of 848
Rapti, A., Androutsopoulou, T., Andreopoulou, E., Mellou, M., Leventakos, G., Anesti, M., Mastori, K., Chatzopoulou, M., Smyrli, P., Lakos, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-01670-3
“These are the chromosome areas quantitively affected by Rb and they have been implicated in the control of stem cell proliferation 70,71 and of the age-related decline in stem cell function 72,73 .”
Noncoding RNAs and RNA Epigenetics in Brain Aging
Sugai-Munson, A., Simon, C., Graves, O. K., McKay, T. B., & Li, H. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_10
Despite research breakthroughs, an anti-aging pill is still a long way off
Bergquist, S. H. (2015) · The Conversation · doi:10.64628/aai.axsprnpva
Libertini, G. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2503325
Yang, J., Gao, W., Huang, F., Zhou, M., Liu, Y., Meng, L., Peng, H. U., & Chen, F. (2025) · Acta Mineralogica Sinica · doi:10.3724/j.1000-4734.2025.45.119
Kim, D., Yoo, S. H., Oh, S. S., Yeon, G., Choi, J., Lee, J., Park, S., Kim, D., & Kim, D. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70118
“…manner represents a distinctive strategy for facilitating or studying cellular aging in the CNS. Previous studies using Tert ‐ deficient mice (Jaskelioff et al. 2011), CRISPR – Cas9 ‐ mediated TERT knockout (Harley et al. 2024), and pharmacological telomerase inhibition (Vera et al. 2016)…”
Pathogenetic markers of cellular senescence
Markina, Y. V., Kirichenko, T. V., Zhivodernikov, I. V., Markin, A. M., Eremin, I. I., Deev, R. V., & Kotenko, K. V. (2025) · I P Pavlov Russian Medical Biological Herald · doi:10.17816/pavlovj634546
Brain Development and Behavioral Ontogenesis
Bleuer‐Elsner, S., Masson, S., Lacoste, M., & Muller, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-06260-4_4
Systems-level modelling of DNA damage, senescence, and stem cell dynamics in ageing
Che, A., Morgan, A. E., & Auley, M. T. M. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113063
Modified hTERT treatment ameliorates pressure overload-induced heart failure
Zhao, Y., Bao, X., Xiong, W., Wan, X., Yu, Q., Wang, T., Chang, A. C. H., Liu, Y., Wang, Y., Shang, C., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106203
“23 63 Telomerase reactivation has been shown to suppress inflammation and promote regeneration in several murine models 64,65 ; however, whether telomere uncap-ping is responsible for myocardial inflammatory response remains unresolved.”
Type 2 Diabetes From the Perspective of Telomere Biology
Cao, H., Feng, H., Shen, Z., & Huang, Y. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70137
“…in TERT knockout mouse models and eliminated degenerative phenotypes in multiple organs including the testes, spleen, and intestine [83]; after the senescent cell lytic agent (dasatinib plus quercetin) eliminated senescent cells in adipose tissue, the survival rate of mice was…”
Blázquez-Moreno, A., Orgaz, L., Rodríguez-Moreno, E., Asensio, A., Marsal, M. F., Mantecón, L., Infante, C., Samper, E., & Flemetakis, E. (2026) · Nutrition and Health · doi:10.1177/02601060261431078
Lemey, C. (2017) · theses.fr (ABES) · doi:10.70675/14dca0fcze537z4da0z9184z9b59c260ea88
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Generation of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Billard, P. (2021) · theses.fr (ABES) · doi:10.70675/7d145f6az2700z4c8bzad56z3286d493fb31
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Soulé, S. (2020) · theses.fr (ABES) · doi:10.70675/55881bfbza629z4e0ez86b6z6709f5af7619 · Cited by 1
Molbert, N. (2020) · theses.fr (ABES) · doi:10.70675/57f2de61zf095z4e12zbd44z3fc3f6b45fde · Cited by 2
Depeux, C. (2020) · theses.fr (ABES) · doi:10.70675/91b4b095za4d3z4888za7f6za92218580ee1
Improvement of fertility in female mice by treatment with novel telomerase-increasing compounds
Abramov, M. M., Har‐Vardi, I., Assenheim, L., Tsory, S., Gil, E. B., & Priel, E. (2026) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-026-01544-x
“In TERT or TERC knockout mice, the absence of telomerase activity resulted in significantly shortened telomeres by the fourth generation, which was associated with infertility [70, 71].”
Telomere dynamics and life-history traits
Remot, F. (2022) · theses.fr (ABES) · doi:10.70675/4f13b16fzd2b9z4e95z8af2z29581b8addb4
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Shen, Y., Zhou, J., Sun, B., & Geng, L. (2026) · Medicine · doi:10.1097/md.0000000000048217
“…shown that reactivation of telomerase in telomerase-deficient mice can reverse several features of brain aging, including neural stem cell proliferation, brain tissue integrity, and olfactory function, [34] providing mechanistic support for the involvement of telomere maintenance in brain aging.”
Wielgosz-Biała, S., Kasprzak, A., Kułaga, M., Grzybek, M., Mazur-Lesińska, D., Szostak, B., Tyszkiewicz, K., Łozowski, B., Kasprzak, M., & Wilczyńska, B. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4992
Reverse aging: Concept, significance, theories and future prospective
Yadav, A., & Kamath, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00011-4
Overview of hallmarks of aging
Sangeeth, A., Subramanian, M., Singh, A., & Singh, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00004-7
Research progress in the anti-aging potential of neural stem cells
Wu, J.-C., Yang, J.-Y., Li, N., & Liu, J. (2025) · Nature Advance · doi:10.61958/natx7823
Csoka, A. B., Stambler, I., West, M. D., Heinbockel, T., Bhowmik, D., Herbig, U., & Stair, S. E. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-20006-8_9
Fedoruk‐Wyszomirska, A., Pawelczak, P., Orlicka-Płocka, M., Gurda, D., Giel-Pietraszuk, M., Przybył, Ł., Framski, G., Pasternak, K., Chmurzyńska, A., & Wyszko, E. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.312
Long Noncoding RNAs in Aging and Cellular Senescence
Tavares-Marcos, C., & de Jesus, B. B. (2026) · Epigenetics and human health · doi:10.1007/978-3-032-19668-2_5
Positioning TERT at the apex of aging
DePinho, R. A. (2026) · Nature Aging · doi:10.1038/s43587-026-01179-y
“Neither adult genetic restoration of TERT nor long-term TAC exposure in mice was reported to increase cancer incidence over the study intervals examined 7,12 .”
InfluentialSelf-citationQian, Z., Chen, Y., Qian, C., & Guo, Q. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106372
To longevity and beyond: A systems view of aging and stress resilience
Sideri, S., Cosentino, M., Forcina, L., & Musarò, A. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112236
Sewell, P. E., & Jensen, C. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1908078
“…studies demonstrate that elevating TERT expression reduces senescence markers, inflammaging, and SASP (senescence-associated secretory phenotype)—the pro-inflammatory secretome that promotes cancer-permissive microenvironments (Morales et al., 1999; Jiang et al., 1999; Jaskelioff et al., 2011).”
Understanding extracellular vesicles in antiaging
Ahmad, P., Estrin, N. E., Sculean, A., & Miron, R. J. (2026) · Periodontology 2000 · doi:10.1111/prd.70070
Telomerase reverse transcriptase as a core regulator of brain health
Shim, H. S., & DePinho, R. A. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.08.003
Self-citationThe Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation
Chmielewski, P. P., & Strzelec, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188080
Shirasuna, K., Shirota, A., & Iwata, H. (2026) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70100
“These hallmarks are grouped into three categories as primary (blue hallmarks), antagonistic (green hallmarks), and integrative (gray hallmarks). telomerase activity suppresses telomere shortening, thereby potentially slowing the senescence process [12, 13].”
Gagliardi, M., Felicetti, A., Procopio, R., Augimeri, A., Morelli, M., Quattrone, A., Annesi, G., & Quattrone, A. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14172-7
“Experimental studies showed that telomere shortening accelerates α-synuclein aggregation, motor decline, microglial dysfunction, and mortality, whereas telomerase reactivation partially restores neural and oligodendroglial function [21, 22].”
The role of telomerase in brain during ageing and under dietary restriction
Czapiewski, R. (2013) · Cited by 1
Progeroid Syndromes: Role of Accelerated Fibroblast Senescence and p38 Activation
Davis, T. (2014) · Springer eBooks · doi:10.1007/978-94-017-9325-4_3
Eggermont, J. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415994-5.00008-7
Functional Analysis of ACD Mutations in Dyskeratosis Congenita.
Koçak, H. (2014) · Deep Blue (University of Michigan)
Metadata
- Authors
- Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., Horner, J. W., Maratos-Flier, E., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2010-11-28
- Volume
- 469
- Issue
- 7328
- Pages
- 102-106
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3057569
- OpenAlex
- W2053352181
- Semantic Scholar
- e8979f16fd203e2da6b0b4ab00099b85b2df9b18
- Cited by
- 857
- References
- 36
- Citations by year
- 2026: 33 · 2025: 42 · 2024: 43 · 2023: 45 · 2022: 43 · 2021: 80 · 2020: 45 · 2019: 54 · 2018: 45 · 2017: 60 · 2016: 55 · 2015: 49 · 2014: 62 · 2013: 70 · 2012: 67
- FWCI
- 43.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (U01CA141508, R01CA084628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase reactivation, telomere elongation, telomere dysfunction, aging, tissue degeneration, DNA damage signaling, regenerative therapy, stem cell depletion, cellular senescence, carcinogenesis risk
- MeSH terms
- Doublecortin Protein, Aging, Animals, Avoidance Learning, Brain, Cell Differentiation, Cells, Cultured, DNA Damage, Enzyme Activation, Enzyme Reactivators, Mice, Inbred C57BL, Myelin Sheath, Organ Size, Phenotype, Receptors, Estrogen, Recombinant Fusion Proteins, Smell, Tamoxifen, Telomere, Telomerase, Models, Animal, Regenerative Medicine, Cell Proliferation, Mice, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.